CXL Ophthalmics is currently developing minimally invasive treatment options for patients with corneal disease.
Dr. Talamo worked in clinical practice for 25 years, specializing in corneal disease, cataract and refractive surgery, according to a Jan. 18 press release.
He then became chief medical officer at Ocular Therapeutix and chief medical officer and worldwide vice president of clinical and medical affairs at Johnson & Johnson.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
